Compare Peptides
Select any two compounds for a side-by-side comparison of mechanism, uses, risks, and FDA regulatory status.
Popular comparisons
A synthetic analog of vasopressin (antidiuretic hormone) FDA-approved for diabetes insipidus, bedwetting, and hemophilia A. One of the most widely prescribed peptide drugs globally.
A synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH). Used clinically to evaluate pituitary function and increasingly prescribed in peptide therapy to maintain endogenous testosterone production during TRT or peptide cycles. Acts on the pituitary to stimulate LH and FSH release.
Selectively activates V2 vasopressin receptors in the kidney collecting ducts, increasing water reabsorption and concentrating urine. Also releases von Willebrand factor and Factor VIII from endothelial stores, aiding blood clotting.
Binds to GnRH receptors on gonadotroph cells in the anterior pituitary, triggering pulsatile release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This maintains the HPG axis feedback loop and preserves testicular function, including spermatogenesis.
- Central diabetes insipidus
- Nocturnal enuresis (bedwetting)
- Hemophilia A (mild)
- Von Willebrand disease
- Nocturia
- Maintaining fertility during TRT
- Pituitary function testing
- Hypothalamic amenorrhea treatment
- Post-cycle therapy (PCT)
- Preserving testicular size during hormone therapy
- Hyponatremia (water intoxication — serious)
- Headache
- Nausea
- Fluid retention
- Seizures if sodium drops too low
- Injection site reactions
- Headache and nausea
- Flushing
- Potential for desensitization with continuous (non-pulsatile) use
- Allergic reactions (rare)
FDA-approved in multiple formulations: DDAVP (nasal spray, injection, tablets), Stimate (nasal spray for bleeding disorders), Nocdurna (sublingual for nocturia). Generic available.
FDA-approved as Factrel for diagnostic evaluation of pituitary gonadotroph function. Lutrelef (pulsatile gonadorelin) approved in 2024 for hypothalamic amenorrhea. Widely compounded for off-label use in fertility preservation during TRT.
- Desmopressin: pharmacology and clinical applications
2007 · PubMed
This comparison is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide therapy.